Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) have developed a novel way to engineer yeast ...

Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...

Liraglutide is under clinical development by Novo Nordisk and currently in Phase III for Obesity. According to GlobalData, Phase III drugs for Obesity have a 44% phase transition success rate (PTSR) ...

Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) have developed a groundbreaking way to engineer yeast (Saccharomyces cerevisiae) to create microbial communities that ... paving the ...

Treatment is only recommended for people ... Candida glabrata is more closely genetically related to baker’s yeast (Saccharomyces cerevisiae) than it is to Candida albicans or Candida parapsilosis.

Probiotics, live microorganisms derived from fermented foods and gut flora, ranging from bacterial strains like Lactobacillus and Bifidobacterium to yeasts such as Saccharomyces cerevisiae var.

Jan. 2, 2025 — Engineers showed that some types of soil bacteria can influence a plant's balance of growth and defense. The bacteria produce an enzyme that can lower a plant's immune activity ...

Brewer’s yeast (Saccharomyces cerevisiae) is a common ingredient ... theorized that vitamin B12 supplementation might help HS treatment through modulating the immune system.

Developing and applying yeast (Saccharomyces cerevisiae) high throughput phenomic screening approaches for deciphering ... Antimicrobial resistance in bacteria and Plasmodium is a threat to treatment ...

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...